Search research articles
Contact Us
Filters
Showing results (981-990 of 4,265) with videos related to
Page
of 427
Sort By:
Cancer Discovery
|
November 1, 2023
A New Wave of PI3Kα Inhibitors
Alison L Kearney, Neil Vasan
Cancer Discovery
|
November 1, 2023
Early Clinical Success of MTA-Cooperative PRMT5 Inhibitors for the Treatment of CDKN2A/MTAP-Deleted Cancers
Kathleen M Mulvaney
Cancer Discovery
|
November 1, 2023
The Promise and Limitations of Neoadjuvant Immune-Checkpoint Blockade in Resectable Non-Small Cell Lung Cancer
Alissa J Cooper, Helena A Yu
Cancer Discovery
|
October 20, 2023
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study
William K Kelly, Daniel C Danila, Chia-Chi Lin, et al.
Cancer Discovery
|
October 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium
Anirban Das, Nicholas R Fernandez, Adrian Levine, et al.
Cancer Discovery
|
October 11, 2023
CAR T-cell Availability for Multiple Myeloma Improving but Still Limited
Cancer Discovery
|
July 21, 2023
F3 Regulates Radiation Therapy-Induced Remodeling and Resistance in Glioblastoma
Cancer Discovery
|
July 25, 2023
Drugs Halt Replication Later than Thought
Cancer Discovery
|
July 7, 2023
Glioma Infiltration and Progression Are Driven by Remote Neuronal Activation
Cancer Discovery
|
August 10, 2023
Might Myeloma Trial Point to Novel Study Approach?
Page
of 427
Search research articles
Search
Showing results (981-990 of 4,265) with videos related to
Sort By:
Page
of 427
Cancer Discovery
|
November 1, 2023
A New Wave of PI3Kα Inhibitors
Alison L Kearney, Neil Vasan
Cancer Discovery
|
November 1, 2023
Early Clinical Success of MTA-Cooperative PRMT5 Inhibitors for the Treatment of CDKN2A/MTAP-Deleted Cancers
Kathleen M Mulvaney
Cancer Discovery
|
November 1, 2023
The Promise and Limitations of Neoadjuvant Immune-Checkpoint Blockade in Resectable Non-Small Cell Lung Cancer
Alissa J Cooper, Helena A Yu
Cancer Discovery
|
October 20, 2023
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study
William K Kelly, Daniel C Danila, Chia-Chi Lin, et al.
Cancer Discovery
|
October 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium
Anirban Das, Nicholas R Fernandez, Adrian Levine, et al.
Cancer Discovery
|
October 11, 2023
CAR T-cell Availability for Multiple Myeloma Improving but Still Limited
Cancer Discovery
|
July 21, 2023
F3 Regulates Radiation Therapy-Induced Remodeling and Resistance in Glioblastoma
Cancer Discovery
|
July 25, 2023
Drugs Halt Replication Later than Thought
Cancer Discovery
|
July 7, 2023
Glioma Infiltration and Progression Are Driven by Remote Neuronal Activation
Cancer Discovery
|
August 10, 2023
Might Myeloma Trial Point to Novel Study Approach?
Page
of 427